Theriva Biologics
TOVX
TOVX
48 hedge funds and large institutions have $9.73M invested in Theriva Biologics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
38% less capital invested
Capital invested by funds: $15.7M → $9.73M (-$6.01M)
Holders
48
Holding in Top 10
1
Calls
$1.66M
Puts
–
Top Buyers
| 1 | +$81K | |
| 2 | +$22.3K | |
| 3 | +$16.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11K |
Top Sellers
| 1 | -$132K | |
| 2 | -$122K | |
| 3 | -$106K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$55K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$16K |